Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
11 drugs in development
By Therapeutic Area
top 6
R&D Momentum
81/100
Pipeline Velocity
56/100
Trial Completion Rate
76/100
Pipeline Concentration
13/100
Pipeline Freshness
52/100
Strategic Signals
Activity
Last 14 days
A Randomized Controlled Trial of Use Versus Non-use of Bladder Catheterization in Elective Cesarean Delivery
A Framework for Research in Emerging Adults: Stepped Care for Youth at Risk of Psychosis
The Differential Effects of THC vs. CBD on Cognition in Persons With MS
Evaluation of Foreign Body Airway Obstruction Interventions Among Young Children: A Prospective Cohort Study
Evaluation of Foreign Body Airway Obstruction Interventions: A Prospective Cohort Study of Adults and Children
A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial
Prospective Evaluation of Foreign Body Airway Obstruction Interventions Among Infants: A Non-randomized Pilot Cohort Study
Prospective Evaluation of Foreign Body Airway Obstruction Interventions Among Adults and Children: A Non-randomized Pilot Cohort Study
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)